WASHINGTON, DC — The Biosimilars Council applauds the unanimous Senate passage of the Affordable Prescriptions for Patients Act led by Senator Cornyn (R-TX) and Senator Blumenthal (D-CT). The bill is aimed at reforming patent abuse in the pharmaceutical industry.“The Biosimilars Council and AAM applauds unanimous Senate passage of the Cornyn-Blumenthal legislation,” said Craig Burton, executive director of the biosimilars council. “Patent thickets are used by brand pharmaceutical companies to maintain high prices and deny patients access to lower-cost medicines. This legislation is a great step in curbing these abuses and will help increase competition and access for biosimilars. We encourage the House to take up this legislation and for Congress to continue working to help lower costs for patients.”
Biosimilars Council applauds patent abuse act
The Biosimilars Council applauds the unanimous Senate passage of the Affordable Prescriptions for Patients Act led by Senator Cornyn (R-TX) and Senator Blumenthal (D-CT). The bill is aimed at reforming patent abuse in the pharmaceutical industry.
Related
Walgreens expands micro-fulfillment network with new Pennsylvania facility
The new facility will serve nearly 650 Walgreens stores, including 55 locations in Pennsylvania, by automating the dispensing of prescription medications.
Albertsons ordered to pay $900 million in Washington opioid case
A Washington judge ordered Albertsons to pay $900 million for inadequately investigating suspicious opioid prescriptions. The retailer may appeal.
Walgreens takes flu prevention campaign to New York with Jordyn Woods partnership
Chain puts prevention at center court as flu activity increases earlier this season.
Latest
HDA Research Foundation announces 2026 Karen J. Ribler supply chain scholars
The program reflects the organization’s ongoing commitment to advancing education, fostering leadership and supporting professional growth across the healthcare supply chain.
The CPG Guys to expand beyond podcasts
Opening new avenues for addressing the industry’s challenges and opportunities.
Consumers back expanded HSA and FSA eligibility for oral care
A CHPA survey found 83% of HSA and FSA holders would use healthcare savings for everyday oral care if eligible, supporting proposed coverage-expansion legislation.